Interferon-α generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection

AIDS

Volumn 15, Issue 13, 2001, Pages 1603-1612

  Siegal, Frederick P ^a,b   Fitzgerald Bocarsly, Patricia ^c   Holland, Bart K ^c   Shodell, Michael ^a,b,d  

^a ST VINCENT S HOSPITAL   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d CW Post Campus of Long Island University ^*  (United States)

Author keywords

AIDS; Cellular immunity; Dendritic cells; HIV; Immunocompromised host; Interferon ; Interferons; Natural immunity; Natural interferon producing cell; Plasmacytoid; T cells; Th1

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MALE; RNA, VIRAL; VIRAL LOAD;

EID: 0035822969     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200109070-00002     Document Type: Article

References (50)

1. Severe acquired immunodeficiency syndrome in male homosexuals: Diminished capacity to make interferon-alpha in vitro is associated with susceptibility to opportunistic infections
2. Opportunistic Infections in Acquired Immune Deficiency Syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity
3. Decreased frequency of functional natural interferon-producing cells in peripheral blood of patients with the acquired immune deficiency syndrome
4. Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV infection
5. Functional deficiencies in two distinct IFN-α producing cell populations in PBMC from human immunodeficiency virus seropositive patients
6. Human natural interferon-alpha producing cells
7. Viral induction of low-frequency interferon-alpha producing cells
8. The cell surface phenotype of human natural interferon-alpha producing cells as determined by flow cytometry
9. Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus
10. Identity of the principal type-I IFN-producing cells in human blood
11. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon
12. Natural interferon alpha/beta-producing cells link innate and adaptive immunity
13. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization
14. T cell activation and polarization by DC1 and DC2
15. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vitro
16. Will the making of plasmacytoid dendritic cells in vitro help unravel their mysteries?
17. Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2′-deoxyadenosine: Implications for susceptibility to opportunistic infections
18. Chapters 4-7, 9-11
19. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients
20. Reciprocal control of T helper cell and dendritic cell differentiation
21. Linking innate and adaptive immunity
22. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
23. Changing patterns of mortality across Europe in patients infected with HIV-1
24. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
25. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
26. Recovery of the immune system with antiretroviral therapy: The end of opportunism?
27. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group Protocol 315
28. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
29. Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy
30. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV cohort study
31. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy
32. Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection
33. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection
34. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
35. Antiretroviral therapy and immune reconstitution
36. Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy
37. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults
38. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy
39. Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy
40. CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients
41. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy
42. Immune reconstitution syndromes in human immunodeficiency virus infection following effective antiretroviral therapy
43. Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy
44. Interferon-α increases the frequency of interferon-γ producing CD4+ T cells
45. Effects of interferon-α on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells
46. The role of stat4 in species-specific regulation of Th cell development by type I IFNs
47. Human peripheral null lymphocytes II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum
48. CD4+ blood dendritic cells are potent producers of IFN-α in response to HIV-1 infection
49. Stimulation of natural interferon-alpha/beta-producing cells by Staphylococcus aureus
50. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40 ligand